Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Jul 7;289(6436):1–2. doi: 10.1136/bmj.289.6436.1

Antidepressants and heart disease.

M L Orme
PMCID: PMC1442048  PMID: 6428642

Full text

PDF
2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burckhardt D., Raeder E., Müller V., Imhof P., Neubauer H. Cardiovascular effects of tricyclic and tetracyclic antidepressants. JAMA. 1978 Jan 16;239(3):213–216. [PubMed] [Google Scholar]
  2. Cassem N. Cardiovascular effects of antidepressants. J Clin Psychiatry. 1982 Nov;43(11 Pt 2):22–29. [PubMed] [Google Scholar]
  3. Coull D. C., Crooks J., Dingwall-Fordyce I., Scott A. M., Wier R. D. Amitriptyline and cardiac disease. Risk of sudden death identified by monitoring system. Lancet. 1970 Sep 19;2(7673):590–591. doi: 10.1016/s0140-6736(70)90169-8. [DOI] [PubMed] [Google Scholar]
  4. Glassman A. H., Bigger J. T., Jr Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. Arch Gen Psychiatry. 1981 Jul;38(7):815–820. doi: 10.1001/archpsyc.1981.01780320095011. [DOI] [PubMed] [Google Scholar]
  5. Glassman A. H., Johnson L. L., Giardina E. G., Walsh B. T., Roose S. P., Cooper T. B., Bigger J. T., Jr The use of imipramine in depressed patients with congestive heart failure. JAMA. 1983 Oct 21;250(15):1997–2001. [PubMed] [Google Scholar]
  6. Himmelhoch J. M., Poust R. I., Mallinger A. G., Hanin I., Neil J. F. Adjustment of lithium dose during lithium-chlorothiazide therapy. Clin Pharmacol Ther. 1977 Aug;22(2):225–227. doi: 10.1002/cpt1977222225. [DOI] [PubMed] [Google Scholar]
  7. Kantor S. J., Bigger J. T., Jr, Glassman A. H., Macken D. L., Perel J. M. Imipramine-induced heart block. A longitudinal case study. JAMA. 1975 Mar 31;231(13):1364–1366. [PubMed] [Google Scholar]
  8. Langou R. A., Van Dyke C., Tahan S. R., Cohen L. S. Cardiovascular manifestations of tricyclic antidepressant overdose. Am Heart J. 1980 Oct;100(4):458–464. doi: 10.1016/0002-8703(80)90657-2. [DOI] [PubMed] [Google Scholar]
  9. Luchins D. J. Review of clinical and animal studies comparing the cardiovascular effects of doxepin and other tricyclic antidepressants. Am J Psychiatry. 1983 Aug;140(8):1006–1009. doi: 10.1176/ajp.140.8.1006. [DOI] [PubMed] [Google Scholar]
  10. Marshall J. B., Forker A. D. Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications. Am Heart J. 1982 Mar;103(3):401–414. doi: 10.1016/0002-8703(82)90281-2. [DOI] [PubMed] [Google Scholar]
  11. Mitchell J. R., Cavanaugh J. H., Arias L., Oates J. A. Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest. 1970 Aug;49(8):1596–1604. doi: 10.1172/JCI106377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Moir D. C., Cornwell W. B., Dingwall-Fordyce I., Crooks J., O'Malley K., Turnbull M. J., Weir R. D. Cardiotoxicity of amitriptyline. Lancet. 1972 Sep 16;2(7777):561–564. doi: 10.1016/s0140-6736(72)91958-7. [DOI] [PubMed] [Google Scholar]
  13. Moir D. C., Dingwall-Fordyce I., Weir R. D. Medicines evaluation and monitoring group. A follow-up study of cardiac patients receiving amitriptyline. Eur J Clin Pharmacol. 1973 Aug;6(2):98–101. doi: 10.1007/BF00562434. [DOI] [PubMed] [Google Scholar]
  14. Ramanathan K. B., Davidson C. Cardiac arrhythmia and imipramine therapy. Br Med J. 1975 Mar 22;1(5959):661–662. doi: 10.1136/bmj.1.5959.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Risch S. C., Groom G. P., Janowsky D. S. The effects of psychotropic drugs on the cardiovascular system. J Clin Psychiatry. 1982 May;43(5 Pt 2):16–31. [PubMed] [Google Scholar]
  16. Sacks M. H., Bonforte R. J., Laser R. P., Dimich I. Cardiovascular complications of imipramine intoxication. JAMA. 1968 Aug 19;205(8):588–590. [PubMed] [Google Scholar]
  17. Singer I., Rotenberg D. Mechanisms of lithium action. N Engl J Med. 1973 Aug 2;289(5):254–260. doi: 10.1056/NEJM197308022890508. [DOI] [PubMed] [Google Scholar]
  18. Tilkian A. G., Schroeder J. S., Kao J., Hultgren H. Effect of lithium on cardiovascular performance: report on extended ambulatory monitoring and exercise testing before and during lithium therapy. Am J Cardiol. 1976 Nov 23;38(6):701–708. doi: 10.1016/0002-9149(76)90346-5. [DOI] [PubMed] [Google Scholar]
  19. Veith R. C., Raskind M. A., Caldwell J. H., Barnes R. F., Gumbrecht G., Ritchie J. L. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med. 1982 Apr 22;306(16):954–959. doi: 10.1056/NEJM198204223061603. [DOI] [PubMed] [Google Scholar]
  20. Vohra J., Burrows G. D., Sloman G. Assessment of cardiovascular side effects of therapeutic doses of tricyclic anti-depressant drugs. Aust N Z J Med. 1975 Feb;5(1):7–11. doi: 10.1111/j.1445-5994.1975.tb03247.x. [DOI] [PubMed] [Google Scholar]
  21. WHITE A. G. METHYLDOPA AND AMITRIPTYLINE. Lancet. 1965 Aug 28;2(7409):441–441. doi: 10.1016/s0140-6736(65)90792-0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES